CryoCrate LLC received a $1.5 million NIH SBIR Phase II grant to produce, test and commercialize “INSTAvitria™”, a novel tissue cryopreservation device system CryoCrate LLC received a $1.5 million NIH SBIR Phase II grant to produce, test and commercialize “INSTAvitria™”, a novel tissue cryopreservation device system Sep 1st 2019
Danforth Investigation for Preserving Sf9 Cells Danforth Investigation for Preserving Sf9 Cells Feb 15th 2018
